Table 1.
Patients’ characteristics
|
Primary diagnosis |
Follow-up | All cancer patients | |||
| W/o synchronous organ metastasis | With synchronous organ metastasis | With metachronous organ metastasis | |||
| Samples, n | 9 | 8 | 5 | 54 | 76 |
| AJCC/UICC I, % | 67 | 0 | 80 | 48 | 47 |
| T1-T2, N0, M0 | |||||
| T1, N1, M0 | |||||
| AJCC/UICC II, % | 11 | 0 | 0 | 28 | 21 |
| T1, N2, M0 | |||||
| T2, N1, M0 | |||||
| T3, N0, M0 | |||||
| AJCC/UICC III, % | 11 | 0 | 20 | 24 | 20 |
| T2, N2, M0 | |||||
| T3, N1, M0 | |||||
| T4, N0, M0 | |||||
| T3, N2, M0 | |||||
| AJCC/UICC IV, % | 11 | 100 | 0 | 0 | 12 |
| T4, N1-2, M0 | |||||
| Every T, N3, M0 every T, every N, M1 | |||||
| Median follow up, after blood taking (d) | 677 | 351 | 169 | 851, 5 | 803 |
| Age at blood taking, median (range) (yr) | 63 (48-77) | 59 (56-68) | 71 (39-83) | 63 (40-86) | 63 (39-86) |
| Sex, m/f | 8/1 | 7/1 | 4/1 | 38/16 | 57/19 |
| P, vs tumor-free volunteers | P = 0.005 | P = 0.002 | P = 0.005 | P = 0.021 | P < 0.001 |
UICC: Union internationale contre le cancer; AJCC: American joint committee on cancer.